
Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 19.6% at $3.40 Wednesday morning after the company announced pricing of a $53.5 million public offering of common stock.
Ocugen shares were otherwise rising during Tuesday's trading session after company announced the FDA lifted its clinical hold on the company's COVID-19 vaccine study in the US.